IPO Offerings This Week
Stealth BioTherapeutics (MITO) is a clinical-stage biotechnology company developing new therapies for the diseases involving mitochondrial dysfunction.
Kaleido Biosciences (KLDO) has filed to raise $100 million in an IPO, and uses what it calls Microbiome Metabolic Therapies to treat urea cycle disorders.
Cirius Therapeutics (CSTX) has filed to raise $86 million from the sale of its common stock in an IPO, and developes a treatment for nonalcoholic steatohepatitis [NASH] with fibrosis.
Poseida Therapeutics (PSTX) intends to raise $115 million from the sale of its common stock in an IPO, and is advancing a pipeline of non-viral delivered CAR-T treatment technologies for various cancers.
IPO Investor Alerts
Looking for updates and access to new and exciting IPO offerings? Register to our IPO investor mailing list and get updates on what next big issues are coming to market. https://wallstreetnewscast.com/profile/ipo-investors/
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was not compensated for this media alert. WSNC, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. As of date of this alert, WSNC, or any of its affiliates, held no positions in securities mentioned above. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.
Safe Harbor Statements:
This website includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial advisor before making any and all investment decisions when investing in these type of securities
- Cannabis Stocks get Upgrade at Oversold Levels - October 10, 2019
- FDA Guidance on CBD Infused Products May Signal Bottom for Stock Sector - August 17, 2019
- Vectorspace AI (VXV) and ESTC Discuss Visualizing Alpha Utilizing Datasets and Canvas - August 8, 2019
- Vectorspace (VXV) Crypto Coin Big Uses for Quant Hedge Funds - July 1, 2019
- BioHemp (BKIT) Added to Watch List as CBD Distribution Play - June 28, 2019
- Hammer Fiber (HMMR) Moves Towards Profit in Earnings Report - June 27, 2019
- Maybe It’s Time to Automate Politicians to History Bin Using AI - April 21, 2019
- Biopharma Growth Opportunities in China, Thurs. April 4th in NYC - April 2, 2019
- IPO Schedule This Week: MITO KLDO CSTX PSTX - February 4, 2019
- IPO Investor Watch: ANCN HKIT HOTH - February 2, 2019